Response to Induction Chemotherapy Predicts Survival in AML: A Single Centre Experience from North India
Journal Title: Indian Journal of Cancer Education and Research - Year 2018, Vol 6, Issue 2
Abstract
Aim: The present study was carried out to analyze the various patient related (e.g. age, sex, performance status), disease related (white blood cell count, cytogenetic and molecular mutational status)and treatment related (delay in treatment initiation and response to induction chemotherapy)variables as predictors of outcome in acute myeloid leukemia (AML) patients presenting to a tertiary care center in North India. Materials and Methods: Thedata of all newly diagnosed de-novo AML patients who presented to our center from January 2015 to December 2017 and opted for chemotherapy was correlated with treatment outcome. Results: Sixty eight patients underwent induction chemotherapy during the study period. Sixteen (23.5%), 49 (72.1%) and 3 (4.4%) were in the favorable, intermediate and adverse risk groups, respectively. Fifteen (22%), 8 (11.7%) and 11 (16.1%) patients were positive for AML-ETO, NPM1, FLT3 mutations (3 patients had FLT3 D835 mutations), respectively. Exon 17 c-kit mutations were seen in 10 (14.7%) patients. We did not observe any exon 8 c-kit mutations in our cohort of patients. Biallelic CEBPA mutations were seen in 6 patients (8.8%). Following induction chemotherapy, 26 (38.2%) patients attained complete remission (CR), 20 (29.4%) achieved incomplete CR (platelet count<100 x 109/L) and 22 (32.4%) were refractory to induction therapy. There were only 3 (4.4%) induction deaths.High TLC was associated with FLT3 mutations (p=0.03) and presence of extra medullary disease correlated with AML-ETO (p=0.02) and c-KIT mutations (p=0.02). There was statistically significant correlation of FLT3-ITD mutation positive patients with risk of relapse (p= 0.001). The 2 yr Overall survival (OS) and Event free survival (EFS) were 39.6% and 22.8%, respectively. In a multivariate analysis, the performance status (PS) and post induction remission status independently predicted survival. Conclusion: Thus our data highlights that PS and post induction remission status translates into better OS.
Authors and Affiliations
Anshul Gupta
Keywords
Related Articles
- EP ID EP569258
- DOI 10.21088/ijcer.2321.9815.6218.2
- Views 77
- Downloads 0
Colorectal Cancer Incidence in Tertiary Health Care Centre-Hyderabad
Background: Colorectal cancer (CRC) is the fourth most common cancer in the world. Its incidence varies worldwide being high in western countries and in older age group and low in developing countries. Though relatively...
A Case series of Head and Neck Cancer: A Conversation with Giants and Legends in Oncology
Third International Meeting of Clinical Practice Guidelines in Oncology–2014 and Indian Perspectives was conducted on December 20th 2014. The conference was organized by the unit of medical oncology, Sri Ramachandra Univ...
A Multicenterstudyof Solid-Pseudo Papillary Tumor of the Pancreas
We report a retrospective study of Solid Pseudo Papillary Tumor (SPPT) of the pancreas, a rare entity, which is a low grade malignant abdominal tumor at manyinstitute; this is relatively frequent in young women, with a d...
Magic Mouth Wash V/s Benzydamine Mouth Wash in Prophylaxis and Treatment of Radiation Induced Oral Mucositis in Patients with Head and Neck Cancers: A Prospective Study
Background: The incidence of mucositis is increased by adding concurrent chemotherapy as well as by altered fractionation radiation. The main aim of the study is to compare the efficiency of magic mouth wash and benzydam...
Induction Chemotherapy in Unresectable or Locally Advanced Head and Neck Squamous Cell Cancer: A Single Center Retrospective Experience
Head and Neck Squamous Cell Carcinoma (HNSCC), have an unsatisfactory prognosis despite intensive local treatment. Single institution retrospective study of 60 patients, who were treated with induction chemotherapy follo...